Key Points
- CEO Kevin Cornwell purchased 1,000 Utah Medical Products shares at an average price of $66.75, investing $66,750 and increasing his ownership by 0.53% to 189,472 shares.
- UTMD reported quarterly EPS of $0.88 on $8.62 million in revenue, with a 30.48% net margin, and pays a quarterly dividend of $0.31 per share—a 1.9% yield.
- The stock opened at $66.80, below its 50-day moving average of $72.97, while analysts maintain a “Hold” consensus; institutional investors own 69.6% of outstanding shares.
Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) CEO Kevin Cornwell purchased 1,000 shares of the stock in a transaction dated Thursday, October 29th. The stock was bought at an average cost of $66.75 per share, with a total value of $66,750.00. Following the completion of the purchase, the chief executive officer owned 189,472 shares in the company, valued at $12,647,256. The trade was a 0.53% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Utah Medical Products Price Performance
Shares of NASDAQ:UTMD opened at $66.80 on Friday. The firm's 50 day simple moving average is $72.97 and its 200 day simple moving average is $67.97. Utah Medical Products, Inc. has a fifty-two week low of $53.66 and a fifty-two week high of $76.89. The company has a market capitalization of $212.42 million, a price-to-earnings ratio of 20.00 and a beta of 0.38.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its quarterly earnings data on Thursday, October 22nd. The medical instruments supplier reported $0.88 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 30.48% and a return on equity of 8.83%. The firm had revenue of $8.62 million during the quarter.
Utah Medical Products Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, October 5th. Stockholders of record on Thursday, September 17th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Thursday, September 17th. Utah Medical Products's dividend payout ratio (DPR) is currently 37.13%.
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised shares of Utah Medical Products from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday, September 9th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock presently has an average rating of "Hold".
View Our Latest Analysis on UTMD
Institutional Investors Weigh In On Utah Medical Products
Several large investors have recently modified their holdings of UTMD. Fifth Third Bancorp bought a new position in shares of Utah Medical Products during the 1st quarter valued at about $43,000. Empowered Funds LLC acquired a new position in shares of Utah Medical Products in the 2nd quarter valued at approximately $225,000. Deutsche Bank AG bought a new stake in Utah Medical Products during the 2nd quarter worth approximately $226,000. Sanctuary Advisors LLC bought a new stake in Utah Medical Products during the 1st quarter worth approximately $225,000. Finally, Sei Investments Co. increased its stake in Utah Medical Products by 11.4% during the 1st quarter. Sei Investments Co. now owns 4,097 shares of the medical instruments supplier's stock worth $254,000 after purchasing an additional 419 shares in the last quarter. 69.60% of the stock is currently owned by institutional investors.
Utah Medical Products Company Profile
(
Get Free Report)
Utah Medical Products, Inc (NASDAQ:UTMD) develops, manufactures and distributes medical devices used primarily in hospital and clinical settings. The company focuses on specialized products for women's health, childbirth, neonatal care, electrosurgery, gastroenterology and related medical applications.
Its product portfolio includes fetal monitoring electrodes and catheters, intrauterine pressure monitoring devices, vacuum-assisted delivery systems, neonatal respiratory and care products, electrosurgical accessories, and other disposable and specialty medical instruments.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
